Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Gemifloxacin MeSH Descriptor Data 2025


MeSH Heading
Gemifloxacin
Tree Number(s)
D03.633.100.612.250
D03.633.100.810.835.830.250.322
Unique ID
D000077735
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077735
Scope Note
A naphthyridine and fluoroquinolone derivative antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used for the treatment of community-acquired pneumonia and acute bacterial infections associated with chronic bronchitis.
Entry Term(s)
7-(3-aminomethyl-4-methoxyimino-pyrrolidine-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-(1,8)-naphthyridine-3-carboxylic acid
Factive
Gemifloxacin Mesylate
LB 20304
LB-20304
LB20304
SB 265805
SB-265805
Pharm Action
Anti-Bacterial Agents
Topoisomerase II Inhibitors
Registry Numbers
OKR68Y0E4T
0
X4S9F8RL01
Related Numbers
175463-14-6
X4S9F8RL01
CAS Type 1 Name
1,8-Naphthyridine-3-carboxylic acid, 7-((4Z)-3-(aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-
Public MeSH Note
2019; GEMIFLOXACIN was indexed under NAPHTHYRIDINES and FLUOROQUINOLONES 1997-2018
History Note
2019 (1997)
Date Established
2019/01/01
Date of Entry
2024/08/09
Revision Date
2024/04/10
Gemifloxacin Preferred
SB-265805 Narrower
LB 20304 Narrower
Gemifloxacin Mesylate Narrower
Factive Narrower
7-(3-aminomethyl-4-methoxyimino-pyrrolidine-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-(1,8)-naphthyridine-3-carboxylic acid Broader
page delivered in 0.146s